NSGO_org
@nsgo_org
Followers
110
Following
72
Media
6
Statuses
23
The Nordic Society of Gynaecological Oncology & Cinical Trial Unit
Joined December 2022
โกDr. Mirza and RUBY Investigator colleagues published on the landing page of NEJM Title: ๐ซ๐๐๐๐๐๐๐๐๐๐ ๐๐๐ ๐ท๐๐๐๐๐๐ ๐จ๐
๐๐๐๐๐๐
๐๐ ๐น๐๐๐๐๐๐๐๐ ๐ฌ๐๐
๐๐๐๐๐๐๐๐ ๐ช๐๐๐๐๐ ย ๐ข https://t.co/ao4zea241Q๐ฃ
#NEJM #RUBY #NSGO #Mirza
0
0
3
๐ Dr. Kristina Lindemann presents TIP for #PEACE ๐ Investigating #palliation in #gynecologic #oncology, this research aims to improve patient-centered care for women battling gynecologic cancers. #ASCO2023 #GynecologicOncology
#NSGOCTUPEACE
https://t.co/l0pO8pm4nU
0
0
2
๐ฌ๐ #ASCO2023 Highlights: NSGO-CTU shines bright! Dr. Mansoor Raza #Mirza and Dr. Kristina Lindemann present groundbreaking work in gynecologic oncology. #ResearchBreakthroughs #GynecologicOncology #NSGO See the TIP on https://t.co/qmX2qJOdW6:
0
0
3
Exciting news! Dr. Mirza presented groundbreaking research on PROs in endometrial cancer patients at #ASCO2023. The study highlights the benefits of dostarlimab plus CP, improving quality of life. Congratulations to the research team! #endometrialcancer #oncology #NSGO #Mirza
0
0
9
Join The #NSGO Annual Meeting 2023 in Reykjavik June 14 - 16! The event features presentations from renowned speakers on various topics, including the latest updates in #clinicaltrials, #surgery, and #radiationtherapy
#NSGO2023 #GynecologicalOncology #Reykjavik #ClinicalTrials
0
0
2
Dr. Mirza shared his knowledge on the latest advancements in #EndometrialCancer at The 12th International #Charitรฉ Mayo Conference 2023 in Berlin last week while connecting with friends, colleagues, and associates. #CharitรฉMayoConference #CancerResearch #DrMirza #NSGOCTU #NOGGO
0
2
6
Prospective evaluation of the tolerability and efficacy of #niraparib dosing based on baseline body weight and platelet count: ๐๐๐ฌ๐ฎ๐ฅ๐ญ๐ฌ ๐๐ซ๐จ๐ฆ ๐ญ๐ก๐ #๐๐๐๐๐/#๐๐๐๐๐-๐๐26/#๐๐๐-3012 #๐ญ๐ซ๐ข๐๐ฅ
pubmed.ncbi.nlm.nih.gov
In PRIMA, similar dose intensity, similar efficacy, and improved safety were observed with the ISD compared with the FSD regimen.
0
0
3
We had the opportunity to welcome the Nordic team from #AstraZeneca at our office in Copenhagen to exchange insights, ideas, & updates on ongoing trials. Thank you CTU ๐๐ซ๐จ๐ฃ๐๐๐ญ ๐๐๐ง๐๐ ๐๐ซ๐ฌ๐ท #Rigshospitalet #GynaecologicalOncology #ClinicalTrials #HealthcareInnovation
1
0
3
Interview with @MirzaCPH on the management of #ovariancancer is already available online! Check it out! ๐บ @ESGO_society @ENYGO_official #NSGO
@IJGConline @IJGCfellows @pedroramirezMD @Joanna86992517
In this interview Prof. Mansoor Raza Mirza and @Joanna86992517 discuss about major achievements in the management of #ovariancancer
https://t.co/d1jejDvz4c Full-text with all interviews: https://t.co/SoQuhM0iGe Video recording and edit by @esragbilir
@ESGO_society @IJGConline
1
3
8
Join us in #Iceland!๐ฎ๐ธ #NSGO ANNUAL MEETING 2023 -> Registration Is Open Until June 8th, 2023 @DrLB @MirzaCPH @agz_eriksson @DrZoiaRazumova @BjerreTrent
@ESGO_society @ENYGO_official
#NSGO2023
https://t.co/1omTYUDbwm
0
4
5
๐๐๐๐๐, ๐๐๐๐-๐๐๐ & ๐๐๐ ๐ฉ๐ซ๐จ๐ฎ๐๐ฅ๐ฒ ๐๐ง๐ง๐จ๐ฎ๐ง๐๐ ๐ญ๐ก๐ ๐ ๐ซ๐จ๐ฎ๐ง๐-๐๐ซ๐๐๐ค๐ข๐ง๐ ๐ซ๐๐ฌ๐ฎ๐ฅ๐ญ๐ฌ ๐จ๐ ๐๐๐๐๐-๐๐6-๐๐๐๐/๐๐๐-3031/๐๐๐๐ ๐ญ๐ซ๐ข๐๐ฅ. https://t.co/d68OfTbAkx
#Endometrial #Cancer #RUBY #NSGO #ENGOT #Dostarlimab #ESMO #SGO
0
3
10
We're very excited about the data that our Medical Director, Mansoor Raza Mirza, will present at the #ESMOVirtualPlenary Monday March 27th about the #RUBYTrial
#NSGOCTU #NSGO #ENGOT #ESMO #EndometrialCancer
#ESMOVirtualPlenary: Do patients with advanced #endometrialcancer benefit from the addition of dostarlimab to first-line platinum-based #chemotherapy? โฐ Join us for the first session - 27 March at 18:30 CEST https://t.co/Tyan0NcF9l
#MedOnc #MedEd #MedTwitter #GynCSM @AACR
0
0
3
#ESMOVirtualPlenary: Do patients with advanced #endometrialcancer benefit from the addition of dostarlimab to first-line platinum-based #chemotherapy? โฐ Join us for the first session - 27 March at 18:30 CEST https://t.co/Tyan0NcF9l
#MedOnc #MedEd #MedTwitter #GynCSM @AACR
1
12
19
#NSGO-CTU will collaborate with #Kancera in our upcoming ovarian cancer study -a combined phase Ib/IIa! https://t.co/U9ngNyKOjq
0
0
1
An interim analysis of the key secondary endpoint showed a median OS of 46.3 months for patients receiving #niraparib vs 43.4 months for patients receiving placebo(HR 0.82, 95% CI 0.56-1.20) in the ITT population - #MansoorRazaMirza, #Rigshospitalet. https://t.co/EmFCjLdlE7
#NSGO
0
0
1
#ESMO Virtual Plenary - Dr. Mansoor Raza Mirza will give a live talk on results from the NORA trial on Dec. 15th at 18.30 โ 19.30 CET. https://t.co/g1DX9aNZ3u
#NORAtrial #ESMO #Gynaeological #Oncology #GSK #NSGO
0
0
2
#NSGO is dedicated to the development of new clinical trials and fostering research studies. Visit https://t.co/X0VznX5ZtJ to find the guidelines & Concept Development Form, which is used for submitting new study proposals to NSGO. #clinicaltrials #research #development #study
0
0
2
๐Last day of #ENGOT @ENYGO_official #GynecologicCancer Academy workshop in Malaga ๐Great #education ๐New #friendship ๐Exciting new #clinicaltrial proposals @ESGO_society @EngageEsgo @nsgo_org #GynOnc @Oslounivsykehus @UniOslo_MED @MirzaCPH
Really super interesting and well organized #ENGOT-@ENYGO_official-Gynecological Cancer Academy Workshop taking in place in Malaga! Learning so much on how to conduct a clinical trial! ๐คฉ @ESGO_society
0
4
24